Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, PR China; Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, PR China.
Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, PR China.
Bioorg Chem. 2023 Oct;139:106759. doi: 10.1016/j.bioorg.2023.106759. Epub 2023 Aug 1.
Poly ADP ribose polymerase-1 (PARP-1), one of the most important members of the PARP protein family, plays a crucial role in DNA damage repair, gene transcription, and apoptosis of cancer cells. In this work, benzofuran[3,2-d]pyrimidine-4(3H)-one was used as a framework to design and synthesize a series of novel PARP-1 inhibitors by introducing thiosemicarbazone or its derivatives into the scafford. Among all the target compounds, 19b and 19c were found to exhibit more potent inhibitory activity and higher selectivity against PARP-1 than Olaparib, especially the latter had an IC value of 0.026 μM against PARP-1 enzyme and a PARP-2/PARP-1 selectivity of 85.19-fold over Olapanib. Apart from strong cytotoxicity against the tested cancer cell lines, 19c was most sensitive to SK-OV-3 cells, with an IC value of 4.98 μM superior to Olaparib. Anti-cancer mechanism studies revealed that 19c could inhibit DNA single-strand breakage repair and aggravate DNA double-strand breakage by inhibiting PARP-1 activity, and promote the apoptosis of cancer cells through the mitochondrial apoptosis pathway.
聚 ADP 核糖聚合酶-1(PARP-1)是 PARP 蛋白家族中最重要的成员之一,在 DNA 损伤修复、基因转录和癌细胞凋亡中发挥着关键作用。在这项工作中,苯并呋喃[3,2-d]嘧啶-4(3H)-酮被用作框架,通过将硫代缩氨基脲或其衍生物引入支架中,设计并合成了一系列新型 PARP-1 抑制剂。在所有的目标化合物中,19b 和 19c 被发现对 PARP-1 具有比奥拉帕利更强的抑制活性和更高的选择性,特别是后者对 PARP-1 酶的 IC 值为 0.026 μM,对奥拉帕利的 PARP-2/PARP-1 选择性为 85.19 倍。除了对测试的癌细胞系具有强烈的细胞毒性外,19c 对 SK-OV-3 细胞最为敏感,IC 值为 4.98 μM,优于奥拉帕利。抗癌机制研究表明,19c 可以通过抑制 PARP-1 活性抑制 DNA 单链断裂修复并加重 DNA 双链断裂,并通过线粒体凋亡途径促进癌细胞凋亡。